Stock listing

PRME Stock Price, News, Filings & Events — Prime Medicine, Inc.

Selected listing: PRME · NASDAQ · USD · US

This page tracks Prime Medicine, Inc.'s PRME:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRME:NASDAQ. PRME:NASDAQ is the stock-level entry point for investors researching Prime Medicine, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prime Medicine, Inc. is a public company traded under the ticker PRME in the American market. With a market capitalization of approximately $532.8 million, the company focuses on advancing its innovative approaches in the field of medicine.

PRME:NASDAQUSDUSUpdated September 11, 2026
Prime Medicine, Inc. logo
Ticker
PRME:NASDAQ
Asset type
Stock
Market cap
$567.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Prime Medicine, Inc. PRME:NASDAQ stock context

This page tracks Prime Medicine, Inc.'s PRME:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRME:NASDAQ. PRME:NASDAQ is the stock-level entry point for investors researching Prime Medicine, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prime Medicine, Inc. is a public company traded under the ticker PRME in the American market. With a market capitalization of approximately $532.8 million, the company focuses on advancing its innovative approaches in the field of medicine.

Latest news from Prime Medicine, Inc.

All Prime Medicine, Inc. news →

Research Prime Medicine, Inc.

Alternate listings